Kim, S. C., Glynn, R. J., Liu, J., Everett, B. M., & Goldfine, A. B. (2014). Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: A cohort study. Acta Diabetol.
シカゴスタイル引用形Kim, Seoyoung C., Robert J. Glynn, Jun Liu, Brendan M. Everett, , Allison B. Goldfine. "Dipeptidyl Peptidase-4 Inhibitors Do Not Increase the Risk of Cardiovascular Events in Type 2 Diabetes: A Cohort Study." Acta Diabetol 2014.
MLA引用形式Kim, Seoyoung C., et al. "Dipeptidyl Peptidase-4 Inhibitors Do Not Increase the Risk of Cardiovascular Events in Type 2 Diabetes: A Cohort Study." Acta Diabetol 2014.
警告: この引用は必ずしも正確ではありません.